Evidence map›Paper›PMID 37668744›Full record

Observational studyInternational journal of colorectal disease2023

Management of adhesive small bowel obstruction: the results of a large retrospective study.

E Maienza, G Godiris-Petit, S Noullet, F Menegaux, N Chereau

Open access · hybridAbstract readObservational Study
In one paragraph

Observational study in International journal of colorectal disease, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 16 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

E MaienzaDepartment of General and Endocrine Surgery, Hospital Pitié Salpêtrière, APHP, Sorbonne University Paris, 47-83 Boulevard de l'Hôpital, 75651, Paris Cedex 13, France.
G Godiris-PetitDepartment of General and Endocrine Surgery, Hospital Pitié Salpêtrière, APHP, Sorbonne University Paris, 47-83 Boulevard de l'Hôpital, 75651, Paris Cedex 13, France.
S NoulletDepartment of General and Endocrine Surgery, Hospital Pitié Salpêtrière, APHP, Sorbonne University Paris, 47-83 Boulevard de l'Hôpital, 75651, Paris Cedex 13, France.
F MenegauxDepartment of General and Endocrine Surgery, Hospital Pitié Salpêtrière, APHP, Sorbonne University Paris, 47-83 Boulevard de l'Hôpital, 75651, Paris Cedex 13, France.
N ChereauDepartment of General and Endocrine Surgery, Hospital Pitié Salpêtrière, APHP, Sorbonne University Paris, 47-83 Boulevard de l'Hôpital, 75651, Paris Cedex 13, France. nathalie.chereau@aphp.fr.
Sorbonne Université · FRAssistance Publique – Hôpitaux de Paris · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPostoperative adhesive small bowel obstruction (SBO) is a frequent cause of hospital admission in a surgical department. Emergency surgery is needed in a majority of patients with bowel ischemia or peritonitis; most adhesive SBO can be managed nonoperatively. Many studies have investigated benefits of using oral water-soluble contrast to manage adhesive SBO. Treatment recommendations are still controversial.

methodsWe conducted an observational retrospective monocentric study to test our protocol of management of SBO using Gastrografin

resultsSeventy-eight percent of patients with SBO were managed nonoperatively, including 183 (36.0%) who finally required surgery. Delayed surgery showed a complete small bowel obstruction in all patients who failed the conservative treatment, and a small bowel resection was necessary in 19 patients (10.0%): among them, only 5 had intestinal ischemia.

conclusionsOur protocol is safe, and it is a valuable strategy in order to accelerate the decision-making process for management of adhesive SBO, with a percentage of risk of late small bowel resection for ischemia esteemed at 0.9%.

Indexed as

Diatrizoate MeglumineIntestinal ObstructionAbdominal PainHumansIntestine, SmallRetrospective StudiesDiatrizoate MeglumineDiagnostic protocolOral gastrografinSmall bowel obstructionWater-soluble contrast agent

Identifiers

PMID37668744
PMCPMC10480247
OpenAlexW4386438299

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.